Sansure Biotech – Startup Investor Profile

Sansure biotech is a manufacturer targeting qPCR diagnostic kits with its innovated technology.

Location: Changsha

Country:

Investment Regions: NA, SEA

Investment Stages: late-stage

Website: http://www.sansure.com.cn/

AI Reasoning: Found evidence of Sansure Biotech acting as investor/LP in a joint venture fund and JV with Asep Medical: the JV agreement and Sansure Fund subscription were announced October 27, 2023 (PR Newswire Nov 21, 2023) and documents show activity in January 2025 relating to a JV funding clarification. The most recent identified investment participation is the October 2023/Jan 2025 items; the latest clear investment-related action located is January 5, 2025 (joint venture funding clarification), which is over 10 months prior to the reference point – however, the October 2025 announcements indicate new activity but are dated Oct 22, 2025 (after the reference point) – those are outside the search timeframe relative to the reference point, so using the last verifiable investment before the reference point gives a gap greater than 12 months. The startup involved was Sepset (Sepset Biosciences Inc.) via the SepSMART JV. Based on the time since the last verifiable investment, assign the appropriate tag.

Not Active – No known investments in the last 12 months.

Low Activity – Only known investments between the last 12 and 6 months.

Active – Known investments between the last 6 and 3 months.

Very Active – Known investments in the last 3 months.